Esteghamati et al.18performed a case–control study involving 76 newly diagnosed patients with T2D and 76 healthy control subjects and found that serum visfatin levels in the T2D group were higher than those in the control group. This evidence concerns the gene NAMPT and type 2 diabetes mellitus.